Millennium Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Millennium Management’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,115	Closed	-$9K	–	7225
2022 Q3	$9K	Buy	+1,115	New	+$18.4K	﹤0.01%	6692
2022 Q2	–	Sell	-869	Closed	-$33K	–	7675
2022 Q1	$33K	Sell	869 -494	-36%	-$17.1K	﹤0.01%	6519
2021 Q4	$77K	Sell	1,363 -47	-3%	-$3.15K	﹤0.01%	6358
2021 Q3	$102K	Sell	1,410 -7,291	-84%	-$558K	﹤0.01%	6430
2021 Q2	$834K	Buy	8,701 +6,388	+276%	+$706K	﹤0.01%	4835
2021 Q1	$342K	Buy	2,313 +1,328	+135%	+$241K	﹤0.01%	5121
2020 Q4	$138K	Buy	+985	New	+$160K	﹤0.01%	4962
2020 Q3	–	Sell	-20,966	Closed	-$3.68M	–	4914
2020 Q2	$3.68M	Buy	20,966 +19,794	+1,689%	+$3.31M	0.01%	2041
2020 Q1	$167K	Sell	1,172 -261	-18%	-$34.5K	﹤0.01%	3444
2019 Q4	$206K	Buy	+1,433	New	+$168K	﹤0.01%	3865
2017 Q3	–	Sell	-44	Closed	-$11K	–	3956
2017 Q2	$11K	Buy	+44	New	+$11.8K	﹤0.01%	3395
2016 Q2	–	Sell	-25	Closed	-$33K	–	3684
2016 Q1	$33K	Buy	+25	New	+$35.6K	﹤0.01%	3172
2015 Q4	–	Sell	-60	Closed	-$66K	–	3846
2015 Q3	$66K	Sell	60 -204	-77%	-$236K	﹤0.01%	3316
2015 Q2	$265K	Sell	264 -3	-1%	-$3.23K	﹤0.01%	2938
2015 Q1	$272K	Sell	267 -1,802	-87%	-$5.95M	﹤0.01%	3099
2014 Q4	$6.9M	Sell	2,069 -143	-6%	-$438K	0.01%	1195
2014 Q3	$6.41M	Sell	2,212 -408	-16%	-$1.35M	0.02%	1137
2014 Q2	$9.97M	Buy	2,620 +370	+16%	+$1.39M	0.03%	828
2014 Q1	$12.2M	Buy	+2,250	New	+$11.8M	0.04%	682

Other funds holding NBSE

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DCMIC

Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Millennium Management's NBSE Position: Q4 2022 in Review

Millennium Management sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q4 2022, closing a stake of 1,115 shares — an estimated $9K sold.

Millennium Management first reported a position in NBSE in Q1 2014 and held it in 19 quarters. The position peaked at $12.2M in Q1 2014. 34 funds tracked by Wall St. Rank hold NBSE as of Q4 2022.

Millennium Management reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Millennium Management sold 1,115 NeuBase Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $9K.
Millennium Management first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2014 and held it in 19 quarters.
Millennium Management's NeuBase Therapeutics, Inc. Common Stock position peaked at $12.2M in Q1 2014.
34 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.